Paid Clinical Trials in Garden Grove, CA
As of July 2026, 48 paid clinical trials are recruiting in Garden Grove, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Garden Grove offers studies at sites including National Institute of Clinical Research for conditions such as Schizophrenia, Major Depressive Disorder (MDD), Ulcerative Colitis, Bipolar I Disorder. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Garden Grove
Trials by drug in Garden Grove
Filter results
Newly added in Garden Grove
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
44 clinical trials
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of Brenipatide in Adult Participants With Schizophrenia
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
A Study to Evaluate the Effect of KarXT on Urological Safety
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Top Research Study Locations in Garden Grove
Researchers run research studies in Garden Grove, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| National Institute of Clinical Research | Alzheimer's Disease, End Stage Kidney Disease, MASH - Metabolic Dysfunction-Associated Steatohepatitis | 5 |
| Collaborative Neuroscience Research, LLC | Bipolar Disorder Type I With Mania, Generalized Anxiety Disorder, Negative Symptoms of Schizophrenia | 4 |
| Neurocrine Clinical Site | Schizophrenia, Bipolar I Disorder, Mania | 4 |
| CenExel | Bipolar I Disorder, Schizophrenia, Treatment Resistant Depression | 3 |
| Collaborative Neuroscience Research - Garden Grove | Bipolar I Disorder, Bipolar II Disorder, Schizophrenia | 3 |
| CenExel CNS - Garden Grove | Schizophrenia, Schizophrenia Disorders | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| Valley View Internal Medicine | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Aligos Investigational Site | Chronic Hepatitis B Infection | 1 |
| Bausch Health | Ulcerative Colitis | 1 |
| CNS Network | Schizophrenia | 1 |
| Collaborative Neuroscience Network | Major Depressive Disorder (MDD) | 1 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Local Institution - 0037 | Schizophrenia | 1 |
| NICRs Research Center | Hypertension (HTN) | 1 |
| National Institute of Clinical Research - Garden Grove | Autosomal Dominant Polycystic Kidney Disease | 1 |
| National Institute of Clinical Research, Inc. | End Stage Kidney Disease | 1 |
| Orange County Ophthalmology | Dry Eye Disease (DED) | 1 |
| Orange County Vascular Access Center | Arteriovenous Fistula, Catheter Complications, Catheter Dysfunction | 1 |
| Paragon Rx Clinical | Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases | 1 |
| Research | Hypertriglyceridemia | 1 |
| Reviva site | Schizophrenia | 1 |
| St. Jude Medical Center | End Stage Kidney Disease | 1 |
| VVCRD Research | Ulcerative Colitis | 1 |
| Valley View Research | Ulcerative Colitis, Ulcerative Colitis Chronic | 1 |
Active & Upcoming Studies in Garden Grove (2026)
Recruiting trials in Garden Grove grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Mental health & behavior (21 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications · Phase 3 · Minerva Neurosciences
Diabetes & metabolic (2 active studies)
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) · Phase 2 · Pfizer
HIV / STI (1 active study)
Cardiovascular (1 active study)
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. · Phase 2 · Novartis Pharmaceuticals
Eye & vision (1 active study)
- A Clinical Study Evaluating Licaminlimab for Dry Eye Disease · Phase 2, Phase 3 · Oculis
Common conditions studied in Garden Grove
- Schizophrenia (12 active studies)
- Major Depressive Disorder (MDD) (4 active studies)
- Ulcerative Colitis (4 active studies)
- Bipolar I Disorder (3 active studies)
- Major Depressive Disorder With Anxious Distress (2 active studies)
- Alzheimer's Disease (1 active study)
Leading research sponsors in Garden Grove
- AstraZeneca
- Neurocrine Biosciences
- AbbVie
- Bristol-Myers Squibb
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Garden Grove?
There are approximately 48 recruiting clinical trials in Garden Grove, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Garden Grove pay participants?
Most recruiting trials in Garden Grove compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Garden Grove?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Garden Grove?
The most common conditions under active study in Garden Grove include Schizophrenia (12), Major Depressive Disorder (MDD) (4), Ulcerative Colitis (4), Bipolar I Disorder (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Garden Grove?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Garden Grove on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Garden Grove?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Garden Grove?
Recruiting research sites in Garden Grove include National Institute of Clinical Research, Collaborative Neuroscience Research, LLC, Neurocrine Clinical Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Garden Grove right now?
The largest active categories in Garden Grove are Mental health & behavior (21), Diabetes & metabolic (2), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.